Browse studies
Find your next paid study
5 recruiting studies matching your filters
Phase 1
A Phase 1/2 Study of Tegavivint (NSC#826393) in Children, Adolescents, and Young Adults With Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
This phase I/II trial evaluates the highest safe dose, side effects, and possible benefits of tegavivint in treating patients with solid tumors that has come b…
Colorectal CarcinomaEndometrial CarcinomaMelanoma+19 more
Children's Oncology GroupNCT04851119
The Project: EveryChild Protocol: A Registry, Eligibility Screening, Biology and Outcome Study
This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patien…
Adrenal Gland PheochromocytomaCarcinoma In SituCentral Nervous System Neoplasm+15 more
Children's Oncology GroupNCT02402244
Phase 2
Phase II Study of Cryoablation and Nirogacestat for Desmoid Tumor
The primary purpose of this protocol is Systemic therapy with oral study agent, nirogacestat, followed by a single cryoablation procedure.
Desmoid Tumor
Nam BuiNCT05949099
A Prospective Analysis of Active Observation in Patients With Desmoid-Type Fibromatosis
The purpose of this study is to closely observe people with desmoid-type fibromatosis over 1 months.
Desmoid Fibromatosis
Memorial Sloan Kettering Cancer CenterNCT04281381
Phase 1
A Phase 1/2 Study of FOG-001 in Participants With Locally Advanced or Metastatic Solid Tumors
The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic solid tumors.
CancerColorectal CancerSolid Tumor+12 more
Parabilis Medicines, Inc.NCT05919264